Dr. Reddy’s to market Sanofi’s vaccine brands in India
The Hindu
Dr. Reddy's secures exclusive rights to distribute Sanofi's seven vaccine brands in India, boosting top-line sales revenue.
Pharma major Dr. Reddy’s Laboratories has received exclusive rights to promote and distribute Sanofi’s seven paediatric and adult vaccine brands in private markets in India. Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U, the seven vaccines, had a combined sales of about ₹426 crore (about $51 million), Dr. Reddy’s said, citing IQVIA MAT February 2024 numbers. These will be a significant addition to top-line sales revenue from April 2024, the company said on Wednesday in a release on the exclusive partnership with Sanofi Healthcare India (SHIPL).
Sanofi will continue to own, manufacture and import these brands to the country, Dr. Reddy’s said.
The vaccine portfolio gives Dr. Reddy’s a strong presence in the vaccine segment, propelling it to the second position among vaccines players in India, the company’s CEO-Branded Markets (India and Emerging Markets) M.V. Ramana said. The partnership is part of the Dr. Reddy’s continuing efforts to become the partner of choice in bringing novel, innovative and trusted drugs to patients in India through strategic collaborations, he said.
Though vaccine confidence reached its highest in India in the last few years, there is much to be done for the rest of the country’s large unvaccinated cohort. “To fulfil our long-term commitment to India and expand our geographic reach, we are pleased to partner with Dr. Reddy’s for exclusive distribution and promotion,” said Preeti Futnani, General Manager India for Vaccines of Sanofi.
Air India has signed an agreement with Bengaluru Airport City Limited (BACL), a subsidiary of Bangalore International Airport Limited (BIAL), to develop a built-to-suit facility for the AME program that will feature modern classrooms, well-equipped laboratories for practical training and a team of qualified trainers.
Zepto raises $350 million in largest domestic fundraise in India, backed by leading financial institutions and notable individuals.
Adani Enterprises Ltd stock dips on NSE and BSE after Kenyan project cancellations and U.S. court allegations.
HSBC Flash India PMI shows uptick in private sector activity, with rising cost pressures and increased prices for customers.
Rupee rises slightly against US dollar amid geopolitical pressures, foreign outflows, and domestic equities; Brent oil surges.
Sensex and Nifty rebound in early trade driven by value buying, bank stock rally, and positive global cues.
The pandemic-induced downturn marked a turning point for cab drivers in Bengaluru. According to Tanveer Pasha, president, Ola and Uber Drivers’ Association, the number of active cabs in the city has dropped from over 1 lakh before the pandemic to just around 30,000 today.
Amazon will likely face an EU investigation next year into whether it favours its own brand products, said sources.
White House addresses bribery charges against Indian billionaire Adani, expresses confidence in U.S.-India relationship.
NTPC Green Energy IPO oversubscribed by 93% on day 2, raising ₹3,960 crore for renewable energy projects.
Chief Economic Advisor advises India Inc to focus on productivity, R&D, and quality over reliance on weak currency for exports.